Latest AusBiotech News | Page 12

Industry-backed plan to navigate Australian biotech into future
Prescient expands PTX-200 AML cohort following additional complete remission
NSW Government launches 20-year roadmap for industry
Global partnership between Australia and USA set to boost Biodesign Australia
New senior appointments for Tessara Therapeutics
Botanix acquires rights to new dermatology product
Biotron says BIT225 against SARS-CoV-2 infection effective in animals
INOViQ announces manufacturing agreement with MP Biomedicals
Cochlear agrees to acquire Oticon Medical
First subjects randomised and dosed in Paradigm’s late-stage trial
Adherium releases next generation respiratory platform integration services
New UK-based business development for Adherium
Opthea announces appointment of two new directors
NSW Government seeks operator for RNA manufacturing
Medlab Clinical confirms northern hemisphere distribution
Volpara Health announces leadership and board changes
Mission to BioKorea to strengthen ties
Zelria Therapeutics executes acquisition of Health House
EpiAxis Therapeutics appoints new chief science officer
Imugene says first cohort two patient dose in phase 1 clinical trial
Botanix confirms presentation of data at upcoming congress
Microbio is step closer to launching its InfectID-BSI tests in Europe
Rhonomed completes institutional component of capital raise
Australian Pavilion returns in-person to BIO 2022
Race receives human ethics approval for new trial
MTPConnect announces support for major new resilience projects
Microba announces new research partnership and senior appointment
Australian healthcare investor urges greater support from peers
Avecho reports positive results for Phase 2 topical CBD osteoarthritis study
NTCELL to be produced in Australia under UTS research agreement
Government launches biotechnology – strategic plan for health and medicine
Dimerix receives R&D tax rebate for last financial year
Neuren receives FDA approval for Pitt Hopkins IND and Phase 2 trial
Large molecule facility doubles size of leading bioanalytical laboratory
BioScience Managers welcomes FDA approval of Saluda technology
Industry concerned by leaked Covid vaccine IP waiver text
US FDA grants new orphan designation to Noxopharm’s Veyonda
Biotron updates on pre-clinical study of BIT225 in Covid
Access savings by registering early for AusMedtech 2022
Australia and Korea sign MoU on vaccine research
Paradigm secures UK approvals for PARA_OA_002 clinical trial
First Participants dosed in ENA Respiratory’s phase 2a study
WA funding programmes open
Neuren receives ethics approval for Angelman Phase 2 trial
‘Gold standard’ commercialisation for biotech
Partnership encourages innovation in how Australian universities and industry collaborate
Telix’s ZIRCON late-stage kidney cancer imaging study completes enrolment
Rebrand for Australia’s largest life sciences venture fund